Michael Morabito
Stock Analyst at Chardan Capital
(0.17)
# 4,394
Out of 5,076 analysts
6
Total ratings
16.67%
Success rate
-13.76%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Morabito
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AKRO Akero Therapeutics | Maintains: Buy | $79 → $81 | $54.44 | +48.80% | 2 | Mar 17, 2021 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $202 → $203 | $579.45 | -64.97% | 2 | Feb 26, 2021 | |
| VKTX Viking Therapeutics | Maintains: Buy | $15 → $20 | $34.55 | -42.11% | 2 | Aug 31, 2020 |
Akero Therapeutics
Mar 17, 2021
Maintains: Buy
Price Target: $79 → $81
Current: $54.44
Upside: +48.80%
Madrigal Pharmaceuticals
Feb 26, 2021
Maintains: Buy
Price Target: $202 → $203
Current: $579.45
Upside: -64.97%
Viking Therapeutics
Aug 31, 2020
Maintains: Buy
Price Target: $15 → $20
Current: $34.55
Upside: -42.11%